ストックスクリーナーアプリを入手
4.51
1.96%
-0.09
アフターアワーズ：
4.51
前日終値:
$4.60
開ける：
$4.68
24時間の取引高:
3,592
Relative Volume:
0.15
時価総額：
$44.61M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-4.04%
1か月 パフォーマンス:
-5.85%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$4.51
$4.68
1週間の範囲:
$4.51
$5.00
52週間の値動き範囲:
$3.81
$10.28
Serina Therapeutics Inc Stock (SER) Company Profile
SER を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
4.51 | 44.61M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Serina Therapeutics Inc (SER) 最新ニュース
Serina secures additional $5 million for Parkinson's trial - MSN
Serina secures additional $5 million for Parkinson's trial By Investing.com - Investing.com Australia
Stocks to Watch: Palantir Technologies, Synaptics, J&J Snack Foods, Serina Therapeutics - MarketWatch
Serina Therapeutics's Shares Up Following $5M of Equity Financing - MarketWatch
Serina Therapeutics Receives Second $5 Mln Tranche To Strengthen Cash Position - Marketscreener.com
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Serina Therapeutics receives funding to advance SER-252 into clinical trial - TipRanks
Serina Therapeutics Secures $5 Million for SER-252 Trials - TipRanks
Serina Therapeutics Receives Second $5 Million Tranche to - GlobeNewswire
Parkinson's Breakthrough: Serina Therapeutics Lands Premium-Priced $5M Investment to Advance Novel Treatment - StockTitan
Stocks to Watch: Serina Therapeutics, Powell Max, Silexion Therapeutics - MarketWatch
Serina Therapeutics Shares Rise After Sale of UniverXome Subsidiary - MarketWatch
Serina Therapeutics Sells UniverXome Subsidiary - MarketWatch
Serina Therapeutics Announces Sale of UniverXome Subsidiary - GlobeNewswire
Serina Therapeutics Achieves Debt-Free Status After $11.2M UniverXome Sale, Sharpens Focus on Parkinson's Drug - StockTitan
Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors - GlobeNewswire
Serina Therapeutics, Inc. Appoints Karen J. Wilson to its Board of Directors -January 14, 2025 at 05:25 pm EST - Marketscreener.com
Serina Therapeutics director Bailey Gregory buys shares worth $17,744 By Investing.com - Investing.com Australia
Serina Therapeutics director Bailey Gregory buys shares worth $17,744 - Investing.com
Serina Therapeutics expands equity incentive plan By Investing.com - Investing.com Australia
Serina Therapeutics expands equity incentive plan - Investing.com India
Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024 - BioSpace
Serina Therapeutics to Present at Tribe Public’s Webinar - GlobeNewswire
Serina Therapeutics to Unveil Breakthrough Parkinson's Treatment Strategy in Upcoming Webinar - StockTitan
Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit - GlobeNewswire
Serina Therapeutics Unveils Breakthrough LNP Technology: Zero Immune Response in Key Testing - StockTitan
Serina raises $10M to develop SER-252 for advanced Parkinson’s - Parkinson's News Today
Serina Therapeutics Raises $10M in Financing - FinSMEs
Serina Therapeutics, Inc. announced that it expects to receive $10 million in funding - Marketscreener.com
Serina Therapeutics Stock Soars Pre-Market On $10M Equity Deal To Fund Parkinson’s Trials: Retail Sentiment Explodes - MSN
Serina Therapeutics Stock Soars Pre-Market On $10M Equity Deal To Fund Parkinson’s Trials: Retail Sentiment Ex - Asianet Newsable
Serina Therapeutics Shares Rise After $10 Million in Financing - MarketWatch
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Benzinga
Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - The Manila Times
Serina Therapeutics secures $10M financing - TipRanks
Serina Therapeutics Secures $10 Million Financing to - GlobeNewswire
Serina Therapeutics Secures $10M Financing for Parkinson's Drug Trial at 120% Premium - StockTitan
Serina Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewswire
Serina Therapeutics Makes Grants to New Employees Under Inducement Plan - The Manila Times
Serina Therapeutics Makes Grants to New Employees Under Inducement Plan - GlobeNewswire Inc.
TSX Composite Capped Index (TOOC) QuotePress Release - The Globe and Mail
Serina Therapeutics Inc trading resumes - TipRanks
AgeX Therapeutics stock hits 52-week low at $5.72 - Investing.com India
AgeX Therapeutics stock hits 52-week low at $5.72 By Investing.com - Investing.com Canada
Serina Therapeutics CDO Presents at Injectables Summit - TipRanks
Serina Therapeutics to Present at the 14th Annual Injectables Summit - GlobeNewswire
SLM initiated with a Buy at BofA - TipRanks
Serina Therapeutics director buys $6.9k in company stock By Investing.com - Investing.com Australia
Serina Therapeutics director buys $6.9k in company stock - Investing.com India
Serina Therapeutics Inc (SER) 財務データ
Serina Therapeutics Inc (SER) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Serina Therapeutics Inc (SER) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Bailey Gregory | Director |
Dec 17 '24 |
Buy |
4.59 |
3,866 |
17,745 |
67,243 |
| Bailey Gregory | Director |
Sep 20 '24 |
Buy |
6.03 |
1,137 |
6,851 |
63,377 |
| Bailey Gregory | Director |
Sep 19 '24 |
Buy |
6.11 |
11,679 |
71,384 |
62,240 |
| Bailey Gregory | Director |
Sep 18 '24 |
Buy |
6.23 |
2,709 |
16,873 |
50,561 |
| MINTZ STEVEN | Director |
Sep 12 '24 |
Buy |
6.47 |
6,000 |
38,814 |
17,443 |
| Bailey Gregory | Director |
Aug 20 '24 |
Buy |
8.25 |
1,776 |
14,652 |
47,582 |
| Bailey Gregory | Director |
Aug 19 '24 |
Buy |
7.93 |
6,400 |
50,760 |
45,806 |
| Bailey Gregory | Director |
Aug 16 '24 |
Buy |
7.31 |
6,400 |
46,780 |
39,406 |
| Bailey Gregory | Director |
Aug 15 '24 |
Buy |
6.65 |
6,400 |
42,577 |
33,006 |
| MINTZ STEVEN | Director |
Aug 15 '24 |
Buy |
6.59 |
7,593 |
50,033 |
11,443 |
1.09%
大文字化:
|
ボリューム (24 時間):